infected fibrin clot model study  suggested
subinhibitory dose produced thickening
dosing regimen provided areas
vancomycin regimen produced peak
vivo phenotypic tolerance observed
constitutive mlsb resistance phenotype
streptogramin b- type antibiotics
brain heart infusion
vitry sur seine
cell wall-active agents
